Lipidviro Tech, Inc. (LPVO) - Financial and Strategic Analysis ReviewLipidViro Tech, Inc. (LTI) was engaged in providing research and development for d-OSAB Therapy, a treatment specifically for cardiovascular disease and stroke, and PathPure, which is a purification process for the production of pathogen-free biologics. In September 2008, the company sold all of its assets to AcquiSci, Inc. These assets include 12 patent applications, together...more
Winteam Pharmaceutical Group Limited (570) - Financial and Strategic Analysis ReviewWinteam Pharmaceutical Group Limited (Winteam) engages in the manufacture and sale of Chinese medicine and pharmaceutical products in the People's Republic of China. The company's principal products include, Qiye Shenan tablet for insomnia, heartburn, or tumors; Nifedipine Sustained tablet, a chemical drug used to sooth high blood pressure and cardiac neuralgia;...more
Southwest Synthetic Pharmaceutical Corporation Ltd. (788) - Financial and Strategic Analysis ReviewSouthwest Synthetic Pharmaceutical Corporation Ltd. (SSPCL) is a publicly held pharmaceutical company that is engaged in the manufacturing, researching, developing and exporting of pharmaceuticals. The company's research and development center is engaged in new products research, new products marketing and new technology and advanced production process development. It manufactures more than thousand tons of bulk pharmaceuticals and a lot of preparation production lines of tablets, capsule and powder for injection, aqueous injection and granule preparation.This comprehensive SWOT profile of Southwest Synthetic Pharmaceutical Corporation Ltd. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of the Profile on...more
Zhejiang Hangzhou Xinfu Pharma Co., Ltd. (2019) - Financial and Strategic Analysis ReviewZhejiang Hangzhou Xinfu Pharma Co., Ltd. (Xinfu), a China-based public share holding company is engaged in production and sale of fine chemical and health care products. It principally focuses in manufacturing range of products including Fine Chemical products;...more
Zhejiang Hisoar Pharmaceutical Co.,LTD. (2099) - Financial and Strategic Analysis ReviewZhejiang Hisoar Pharmaceutical Co.,LTD. (Hisoar), a public share holding company is engaged in the production and sale of drug substances and drug intermediates. The company principally operates in China and also has global presence offering various active...more
PT. Pyridam Farma Tbk. (PYFA) - Financial and Strategic Analysis ReviewPT. Pyridam Farma Tbk. (Pyridam) is a pharmaceutical company engaged in the manufacture of cosmetics, food supplements, over the counter (OTC) and prescription drugs. The pharmaceutical formulations of the company are manufactured in the form of tablets, caplets, capsules, syrups, creams and ointment. It also produces prescription drugs such as penicillin and non-penicillin antibiotics, anti-tuberculosis, painkillers, and non-prescription products such as vitamins, flu and cough preparations, and antipyretics. Pyridam is also into marketing of medical supply products that include laboratory reagents and disposable medical supplies.This comprehensive SWOT profile of PT. Pyridam Farma Tbk. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part...more
SemBiosys Genetics Inc. (SBS) - Financial and Strategic Analysis ReviewSemBioSys Genetics Inc. (SemBioSys) is a palnt biotechnology company, that is engaged in the development of pharmaceutical and non-pharmaceutical products to treat various...more
Pharmesis International Ltd. (P31) - Financial and Strategic Analysis ReviewPharmesis International Ltd. (Pharmesis) is a pharmaceutical company that manufactures western medicine and traditional Chinese medicine principally for the treatment of...more
Zhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic Analysis ReviewZhejiang Hisun Pharmaceutical Co. Ltd. (Hisun), a China-based public share holding company is engaged in the manufacture and sale of bulk drugs. It principally...more
Tianjin Tasly Pharmaceutical Co., Ltd. (600535) - Financial and Strategic Analysis ReviewTianjin Tasly Pharmaceutical Co. Ltd. (Tasly) is a pharmaceutical company engaged in the development, manufacturing and distribution of chemical medicine,...more
Suven Life Sciences Ltd. (530239) - Financial and Strategic Analysis ReviewSuven Life Sciences Ltd. (Suven) is a biotechnology company engaged in the business of design, manufacture and supply of bulk actives, drug intermediates and fine chemicals,...more